asrm_logo_color_tagline.png
Menu

News and Research

FDA Updates Information for HCT/P Establishments Regarding the COVID-19 Pandemic

The U.S. Food and Drug Administration (FDA) has issued updated information for facilities and medical professionals handling human cell, tissue, or cellular or tissue-based products (HCT/P) with regard to the COVID-19 pandemic, and now, the COVID-19 vaccines. The FDA emphasizes that there have been no reported cases of transmission of COVID-19 via human cell, tissue, or cellular, or tissue-based products.

Scam Alert!

ASRM does not distribute for sale any meeting attendee lists.  Solicitations sent out offering such lists for sale are a scam.

Quick Links

Learn More About ASRM

Thousands of doctors, nurses, and other professionals in the field of reproductive medicine are advancing their careers with the latest news, continuing education, discounts, and networking opportunities. 

Ready to Join?  |  Renew